Arthritis Care Res (Hoboken) 64:30–37CrossRef 7 Cruz-Jentoft AJ,

Arthritis Care Res (Hoboken) 64:30–37CrossRef 7. Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, Martin FC, selleck inhibitor Michel JP, Rolland Y, Schneider SM, Topinková E, Vandewoude M, Zamboni M (2010) European Working

Group on Sarcopenia in Older People. Sarcopenia: European consensus on definition Smoothened Agonist nmr and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing 39:412–423PubMedCrossRef 8. Lexell J (1995) Human aging, muscle mass, and fiber type composition. Gerontol A Biol Sci Med Sci 50:S11–S16 9. Joseph C, Kenny AM, Taxel P, Lorenzo JA, Duque G, Kuchel GA (2005) Role of endocrine-immune dysregulation in osteoporosis, sarcopenia, frailty and fracture risk. Mol Aspects Med 26:181–201PubMedCrossRef 10. Perrini S, Laviola L, Carreira MC, Cignarelli A, Natalicchio A, Giorgino F (2010) The GH/IGF1 axis and signaling pathways in the muscle and bone: mechanisms underlying age-related skeletal muscle wasting and osteoporosis. J Endocrinol U0126 205:201–210PubMedCrossRef 11. Glass DJ (2010) Signaling pathways perturbing muscle mass. Curr Opin Clin Nutr Metab Care 13:225–229PubMedCrossRef 12. Morley JE (2008) Sarcopenia: diagnosis and treatment. Nutr Health Aging 12:452–456CrossRef 13. Andreoli A, Celi M, Volpe SL, Sorge R, Tarantino U (2012) Long-term effect of exercise on bone mineral density and body composition in post-menopausal ex-elite athletes: a retrospective

study. Eur J Clin Nutr 66:69–74PubMedCrossRef 14. Harris WH (1969) Traumatic arthritis of

the hip after dislocation and acetabular fractures: treatment by mold arthroplasty. An end-result study using a new method of result evaluation. J Bone Joint Surg Am 51:737–755PubMed 15. Pisani V, Panico MB, Terracciano C, Bonifazi E, Meola G, Novelli G, Bernardi G, Angelini C, Massa R (2008) Preferential central nucleation of type 2 myofibers is an invariable feature of myotonic dystrophy type 2. Muscle Nerve 38:1405–1411PubMedCrossRef 16. Brooke MH, Engel WK (1969) The histographic analysis of human muscle biopsies with regard to fiber types: 2. Diseases of the upper and lower motor neuron. Neurology 19:378–393PubMedCrossRef 17. Dubowitz V, Sewry CA (2007) Muscle biopsy: a practical approach, 3rd edn. Saunders, Methocarbamol Elsevier, New York, pp 75–123CrossRef 18. Terracciano C, Nogalska A, Engel WK, Askanas V (2010) In AbetaPP-overexpressing cultured human muscle fibers proteasome inhibition enhances phosphorylation of AbetaPP751 and GSK3beta activation: effects mitigated by lithium and apparently relevant to sporadic inclusion-body myositis. J Neurochem 112:389–396PubMedCrossRef 19. Sato Y, Inose M, Higuchi I, Higuchi F, Kondo I (2002) Changes in the supporting muscles of the fractured hip in elderly women. Bone 30:325–330PubMedCrossRef 20. Schakman O, Gilson H, Thissen JP (2008) Mechanisms of glucocorticoid-induced myopathy. Endocrinology 197:1–10CrossRef 21.

Comments are closed.